Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211730 · ClinicalTrials.gov registry record · Phase 4
Study of Glycemic Control on Liver Transplantation Outcomes
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 164
- Enrollment target
NCT01211730 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 164 participants.
The verdict
NCT01211730, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 164 participants
- Enrollment target
Study Summary
Many but not all studies have shown improvement in morbidity and mortality with intensive glycemic management postoperatively. In this study, the investigators propose to determine whether improved glycemic control using intensive insulin treatment immediately postoperatively will improve outcomes in patients undergoing liver transplant using a prospective, controlled, randomized, parallel-group study design targeting two different glucose levels, 140 and 180 mg/dL.
Interventions
- DRUG Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2009-04 |
| Est. Completion | 2016-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01211730
The ClinicalTrials.gov registry entry for NCT01211730 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin is the first listed.
NCT01211730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01211730 about?
NCT01211730 is a clinical study titled "Study of Glycemic Control on Liver Transplantation Outcomes". Many but not all studies have shown improvement in morbidity and mortality with intensive glycemic management postoperatively. In this study, the investigators propose to determine whether improved glycemic control using intensive insulin treatment immediately postoperatively will improve outcomes i...
What is the current status of trial NCT01211730?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 164 participants. The study started on 2009-04. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01211730?
The interventions under investigation include: Insulin (DRUG).
Who is sponsoring clinical trial NCT01211730?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.